Pharmaceutical

Tirzepatide outpacing Wegovy in the obesity space

Eli Lilly and Novo Nordisk have been competing in the obesity market for the pas...

The unmet need in T2-low asthma: A critical gap in trea...

Severe asthma is traditionally classified into either high or low T-helper cell ...

Expanding diagnostic and biomarker options to improve M...

Distinguishing the stages of fibrosis in MASH is a pressing need for diagnoses a...

IIT Guwahati and Bose Institute develop injectable hydr...

The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata...

From Davids to Goliaths: the GLP-1RA gold rush

There are now more than 300 GLP-1Rs in an active stage of development, from indu...

SIGA’s antiviral approved in Japan for orthopoxvirus tr...

SIGA Technologies has gained the Japanese regulatory approval for TEPOXX (tecovi...

China’s NMPA prioritises HUTCHMED’s lung cancer therapy...

China NMPA has granted acceptance and priority review for the NDA for HUTCHMED’s...

Innovent and Roche link on lung cancer therapy development

Innovent and Roche have entered a partnership and exclusive licence agreement to...

Sangamo’s stock sinks 50% as Pfizer halts haemophilia A...

Sangamo said it plans to explore all options to commercialise the asset, includi...

Tevimbra by BeiGene for Muscle Invasive Bladder Cancer ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for ...

Tevimbra by BeiGene for Gallbladder Cancer: Likelihood ...

Tevimbra is under clinical development by BeiGene and currently in Phase II for ...

Iptacopan hydrochloride by Novartis for Granulomatosis ...

Iptacopan hydrochloride is under clinical development by Novartis and currently ...

CT-7439 by Carrick Therapeutics for Breast Cancer: Like...

CT-7439 is under clinical development by Carrick Therapeutics and currently in P...

ITM-91 by ITM Isotope Technologies Munich for Metastati...

ITM-91 is under clinical development by ITM Isotope Technologies Munich and curr...

ITM-91 by ITM Isotope Technologies Munich for Pancreati...

ITM-91 is under clinical development by ITM Isotope Technologies Munich and curr...

Tebapivat by Agios Pharmaceuticals for Sickle Cell Dise...

Tebapivat is under clinical development by Agios Pharmaceuticals and currently i...